Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$80.52 - $93.75 $40,260 - $46,875
500 Added 19.61%
3,050 $258,000
Q1 2021

May 11, 2021

SELL
$83.5 - $98.47 $35.1 Million - $41.4 Million
-420,503 Reduced 99.4%
2,550 $218,000
Q4 2020

Feb 09, 2021

SELL
$78.07 - $94.43 $1.2 Million - $1.45 Million
-15,307 Reduced 3.49%
423,053 $39.9 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $376,283 - $416,871
-4,581 Reduced 1.03%
438,360 $38.1 Million
Q2 2020

Aug 07, 2020

SELL
$80.93 - $91.1 $14.1 Million - $15.9 Million
-174,283 Reduced 28.24%
442,941 $38.7 Million
Q1 2020

May 08, 2020

SELL
$70.67 - $99.01 $2.97 Million - $4.16 Million
-42,009 Reduced 6.37%
617,224 $50.9 Million
Q4 2019

Feb 06, 2020

SELL
$84.35 - $95.37 $684,162 - $773,546
-8,111 Reduced 1.22%
659,233 $62.4 Million
Q3 2019

Nov 12, 2019

SELL
$85.54 - $94.26 $8.02 Million - $8.84 Million
-93,815 Reduced 12.33%
667,344 $58 Million
Q2 2019

Aug 12, 2019

SELL
$75.4 - $92.8 $5.9 Million - $7.26 Million
-78,219 Reduced 9.32%
761,159 $69.5 Million
Q1 2019

May 10, 2019

SELL
$75.32 - $86.15 $5.44 Million - $6.22 Million
-72,257 Reduced 7.93%
839,378 $71 Million
Q4 2018

Feb 12, 2019

SELL
$73.66 - $82.02 $912,721 - $1.02 Million
-12,391 Reduced 1.34%
911,635 $78.2 Million
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $3.47 Million - $4.02 Million
-51,891 Reduced 5.32%
924,026 $79.6 Million
Q2 2018

Aug 02, 2018

BUY
$64.91 - $73.36 $51.9 Million - $58.7 Million
799,580 Added 453.44%
975,917 $73.7 Million
Q1 2018

May 11, 2018

SELL
$70.39 - $84.15 $300,213 - $358,899
-4,265 Reduced 2.36%
176,337 $14.3 Million
Q4 2017

Feb 09, 2018

BUY
$72.33 - $77.64 $327,220 - $351,243
4,524 Added 2.57%
180,602 $15.2 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $13.1 Million - $13.6 Million
176,078
176,078 $15.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.